approval · primary record
TISLELIZUMAB-JSGR
FDA · BLA · 2024-12-26
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2024-12-26 |
| Brand | TEVIMBRA |
| Sponsor | BEIGENE |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:41.176Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TISLELIZUMAB-JSGR:2024-12-26
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.